HomeInsightsStock Comparison

Emerald Finance Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Emerald Finance Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 26, 2025

Key Highlights

  • The Latest Trading Price of Emerald Finance Ltd is ₹ 100 as of 26 May 10:38.
  • The P/E Ratio of Emerald Finance Ltd changed from 7.6 on March 2020 to 26.7 on March 2024 . This represents a CAGR of 28.57% over 5 yearsThe P/E Ratio of Novelix Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Emerald Finance Ltd changed from ₹ 9.86 crore on March 2020 to ₹ 110.42 crore on March 2024 . This represents a CAGR of 62.12% over 5 yearsThe Market Cap of Novelix Pharmaceuticals Ltd changed from ₹ 1.57 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Emerald Finance Ltd for the Mar '25 is ₹ 6.5 crore as compare to the Dec '24 revenue of ₹ 5.74 crore. This represent the growth of 13.24% The revenue of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Emerald Finance Ltd for the Mar '25 is ₹ 4.53 crore as compare to the Dec '24 ebitda of ₹ 4.09 crore. This represent the growth of 10.76% The ebitda of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Emerald Finance Ltd changed from ₹ 0.86 crore to ₹ 2.65 crore over 8 quarters. This represents a CAGR of 75.54% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Emerald Finance Ltd changed from 38.97 % on March 2020 to 10.01 % on March 2024 . This represents a CAGR of -23.80% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Emerald Finance Ltd

  • Emerald Finance Limited was originally incorporated with the name 'Emerald Leasing Finance and Investment Company Limited' on November 22, 1983.
  • The Company is a NBFC registered with RBI dated December 15, 2018.
  • The Company later on changed the name to Emerald Finance Limited from Emerald Leasing Finance and Investment Company Limited' on April 24, 2023. Initially, the Company engaged in the business of providing services to banks and financial institutions by acting as direct selling agents for their various financial products. empanelled with more than 14 financial institutions which includes, Housing Development Finance Corporation Limited (HDFC Limited), Dewan Housing Finance Limited (DHFL), Tata Capital Housing Finance Limited, Magma Fincorp Limited, Kotak Mahindra Bank Limited, PNB Housing Finance Limited, Indiabulls Housing Finance Limited, Fullerton India Credit Company Limited, L&T Housing Finance Limited, Cholamandalam Investment & Finance Company Limited among others.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

Emerald Finance Ltd News Hub

News

Board of Emerald Finance recommends final dividend

Emerald Finance announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 2025 12:34

News

Emerald Finance to table results

Emerald Finance will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

17 May 2025 16:17

News

Emerald Finance to hold board meeting

Emerald Finance will hold a meeting of the Board of Directors of the Company on 20 March 2...

Read more

18 Mar 2025 10:24

News

Emerald Finance gains after tieup with H.K. Jewels

This partnership aims to provide instant financial relief to employees by allowing them to...

Read more

12 Mar 2025 14:59

News

Emerald Finance to hold EGM

Emerald Finance announced that an Extra Ordinary General Meeting (EGM) of the Company will...

Read more

03 Mar 2025 16:14

News

Emerald Finance to convene board meeting

Emerald Finance will hold a meeting of the Board of Directors of the Company on 1 March 20...

Read more

26 Feb 2025 17:02

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to convene board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27...

Read more

21 May 2025 16:50

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

News

Trimurthi to hold board meeting

Trimurthi will hold a meeting of the Board of Directors of the Company on 14 October 2024....

Read more

08 Oct 2024 10:44

SWOT Analysis Of Emerald Finance Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Emerald Finance Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Emerald Finance Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Emerald Finance Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Emerald Finance Ltd is 340 Cr while Market cap of Novelix Pharmaceuticals Ltd is 69 Cr

What are the key factors driving the stock performance of Emerald Finance Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Emerald Finance Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emerald Finance Ltd and Novelix Pharmaceuticals Ltd?

As of May 26, 2025, the Emerald Finance Ltd stock price is INR ₹98.65. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹27.94.

How do dividend payouts of Emerald Finance Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Emerald Finance Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions